in onset and wears off more rapidly than most other mydriatics. Its uses are generally much the same as those described for other mydriatics. [1, 2] Since tropicamide use is increasing, it is very much essential to develop simple and suitable analytical method for its quantification in bulks and formulations. Such method should provide proper 
INTRODUCTION

Tropicamide (TPC), [Scheme 1] (R,S)-N-ethyl-3-
hydroxy-2-phenyl-N-(pyrid-4-ylmethyl) propionamide, is a tropic acid derivative endowed with short duration of antimuscarinic activity and available in 0.5 and 1% ophthalmic solutions. Its maximum effect is achieved in about 20-25 min and lasts about 20 min, with complete recovery being noted in about 6 h. Its action is more rapid sensitivity and selectivity and could be easily adapted for routine quality control analysis, preformulation or similar studies.
There is little information in the literature for quantification of tropicamide in pharmaceutical raw materials and dosage forms. [3, 4] The reported analytical methods for determination of TPC are TLC, [5] spectrophotometry, [6−8] and HPLC. [9, 10] The United States Pharmacopoeia (USP) and British Pharmacopoeia (BP) [11, 12] have described a nonaqueous titration for determination of tropicamide in raw material and an extractive spectrophotometric method for its pharmaceutical preparations. These methods are time consuming and costly for routine analysis. Therefore, having a simple, fast, and accurate method for determination of TPC in raw material and pharmaceutical dosage forms, which can be used in quality control laboratories is a necessity.
Extractive spectrophotometric procedures are popular for their sensitivity in the assay of drugs. The wellestablished spectrophotometric method employed ion-pair extraction. In this case, an ion-pair is formed between basic pharmaceutical compounds and an anionic dye such as bromocresol purple (BCP) and methyl orange (MO). At a specific pH, the ion-pair is extracted into an organic solvent, which is immiscible with water, and the concentration of the resulting ion pair in the organic phase is determined spectrophotometrically. [13−19] The present study aims to develop accurate, reproducible, less time consuming, and adequately sensitive validated extractive spectrophotometric methods based on the formation of ion-pair complexes between TPC with bromocresol purple (BCP) and methyl orange (MO). The proposed methods were applied to the determination of TPC in tablets dosage form. No interference was observed in the assay of TPC from common excipients in levels found in dosage form. These methods are validated by the statistical data and can be adopted by the pharmaceutical laboratories for industrial quality control.
MATERIALS AND METHODS
Apparatus
All absorption spectra were made using Optima UV-VIS spectrometer (SP-3000 plus) (Tokyo, Japan), equipped with 10 mm matched quartz cells. Hanna pH-meter instrument (pH 211) (Romania) was used for checking the pH of Buffer solutions.
Materials and reagents
All chemicals and reagents were of analytical grade and water was always bidistilled water.
Materials
Tropicamide (TPC) was kindly supplied by Alexandria pharmaceutical Industries Company (Alex), Alexandria, Egypt.
Pharmaceutical formulations
Mydrapid drops (Alex, Alexandria, Egypt), labeled to contain (0.5% and 1.0%) TPC.
Standard solution
A stock standard solution (100 µg ml −1 ) and (1.0 × 10 −3 M) of TPC were prepared by dissolving appropriate weight 0.01 and 0.0284 g, respectively of pure TPC in 10 ml of methanol and further diluted with double distilled water up to the mark in 100 ml volumetric flask. Working standard solutions were prepared by suitable dilution of stock standard solution with bidistilled water. The solution remained stable for 1 month when kept refrigerated.
Reagents
Bromocresol purple (BCP) and methyl orange (MO) (BDH Chemicals LTD, Poole, England) and used without further purification.
A stock solution (1.0 × 10 −3 M) was prepared by dissolving the appropriate weight of bromocresol purple (BCP) and methyl orange (MO) in 10 ml methanol and diluted to 100 ml with bidistilled water.
These solutions are stable for at least 1 week if kept in the refrigerator.
Series of buffer solutions of KCl-HCl (pH 1.5-4.2), NaOAc-HCl (pH 1.99-4.92), NaOAc-AcOH (pH 2.8-6.0) and potassium hydrogen phthalate-HCl (pH 2.0-6.0) were prepared by following the standard methods. [20] Freshly prepared solutions were always employed.
Construction of calibration curves
Aliquots of TPC ranging from 0.1 to 1.6 ml of standard solution (100 µg l −1 ) were transferred into a series of 100 ml separating funnels. To each separating funnel 2.0 ml of BCP or MO (1.0 × 10 −3 M) reagent solutions and 3.0 ml potassium hydrogen phthalate-HCl buffer of pH 3.0, were added and the volume of the aqueous layer was adjusted to 10 ml with distilled water. The mixture was extracted twice with 2.0 × 5.0 ml chloroform by shaking for 2.0 min, then allowed to stand for clear separation of the two phases and the chloroform layer was passed through anhydrous sodium sulphate. The chloroform extracts were collected and diluted to 10 ml with chloroform. The absorbance of the yellow colored complexes were measured at 408 and 427 nm using BCP and MO, respectively against the reagent blank similarly prepared. All measurements were made at room temperature (25 ± 2°C). The procedures were repeated for other analyte aliquots and calibration plots were drawn to calculate the amount of drug in unknown analyte samples.
Procedure for determination of TPC in dosage form
The content of five eye drop container were mixed in a beaker and the average volume of one eye drop container was determined and transferred into 100 ml volumetric flask and completed to 100 ml with bidistilled water and further dilution with bidistilled water was carried out to obtain test solution of 100 mg ml −1 of TPC. The general procedures described above were used for the determination of TPC concentration.
RESULTS
Absorption spectra
The nitrogenous drugs are present in positively charged protonated forms and acidic dyes present mainly in anionic form at pH ≥ 2.5. So when treated with an acid dye at pH range (2.0-6.0) of potassium hydrogen phthalate-HCl buffer, a yellow ion-pair complex which is extracted with chloroform is formed. The absorption spectra of the ionpair complexes, which were formed between TPC and each of BCP and MO were measured in the range 350-550 nm against the blank solution. The ion-pair complexes show maximum absorbance at 408 and 427 nm using BCP and MO methods, respectively. The optimum reaction conditions for determination of the ion-pair complexes were established. Then linearity, accuracy, precision, sensitivity, and stability of proposed methods were described and these developed methods applied to pharmaceutical preparations and obtained results evaluated statistically.
Optimum reaction conditions for complex formation
The optimization of the methods was carefully studied to achieve complete reaction formation, highest sensitivity and maximum absorbance. Reaction conditions of the ion-pair complex were found by studying with preliminary experiments such as pH of buffer, type of organic solvent, volumes of the dye, and shaking time for the extraction of ion-pair complexes.
Selecting of the extracting solvents
The effect of several extracting organic solvents on the ion-pair complex was examined. Chloroform, carbon tetrachloride, ethyl acetate, diethylether, toluene, 1,2-dichloroethane and dichloromethane were tried for effective extraction of the colored ion pair complex from aqueous phase. Chloroform was found to be the most suitable solvent for extraction of colored complex through double extraction with 5.0 ml each time, because of its higher efficiency on color intensity, selective extraction of the ion-pair complex from the aqueous phase, obtained highest absorbance with chloroform and considerably lower extraction ability for the reagent blank and the shortest time to reach the equilibrium between both chloroform and aqueous phases.
Effect of time and temperature
The optimum reaction time was investigated from 0.5 to 4.0 min by following the color development at ambient temperature (25 ± 2°C). Complete color intensity was attained after 2.0 min of mixing for all complexes. Raising the temperature up to 30°C had no effect on the absorbance of the formed complexes, whereas above 30°C, the absorbance started to decay. The absorbance remained stable for at least 24 h.
Effects of pH on the ion-pair formation
The effect of pH was studied by extracting the colored complexes in the presence of various buffers such as KCl-HCl (pH 1.5-4.2), NaOAc-HCl (pH 1.99-4.92), NaOAc-AcOH (pH 2.8-6.0), and potassium hydrogen phthalate-HCl (pH 2.0-6.0). It was noticed that the maximum color intensity and highest absorbance value were observed in potassium hydrogen phthalate-HCl buffer of pH 3.0 is the optimum pH values of buffer using BCP and MO, respectively. In addition to the stability of the color without affecting the absorbance at the optimum pH values [ Figure 1 ]. Further, 3.0 ml of phthalate buffer gave maximum absorbances and reproducible results.
Effects of reagents concentration
The effect of the reagents was studied by measuring the absorbance of solutions containing a fixed concentration of TPC (10 µg ml −1 ) and varied amounts of the respective reagent. Maximum color intensity of the complex was achieved with 2.0 ml of BCP or MO (1.0 × 10 −3 M) reagent solutions, respectively. Although a larger volume of the reagent had no pronounced effect on the absorbances of the formed ion-pair complex [ Figure 2 ].
Effect of sequence of mixing
The most favorable sequence was (drug-reagent-buffersolvent) for the highest color intensity and the shortest time for developing maximum absorbance, while the other sequences require longer time and produce lower absorbance values.
Stoichiometric relationship
Job's method of continuous variation and mole-ratio method [21, 22] of equimolar solutions was employed: A 1.0 × 10 −4 M standard solution of drug base and 1.0 × 10 −4 M solution of BCP and MO, respectively, were used. A series of solutions was prepared in which the total volume of drug and reagent was kept at 10 ml for BCP and MO, respectively. The absorbance was measured at the optimum wavelength. The molar ratio of the reagents (drug: dye) in the ion-pair complexes was determined by the continuous variations method (Job's method) [ Figure 3 ].
The results indicate that 1:1 (drug:dye) ion-pairs are formed through the electrostatic attraction between positive protonated TPC + and negative BCP − and MO − . The extraction equilibrium can be represented as follows:
where TDF + and D − represent the protonated TDF and the anion of the dye, respectively, and the subscript (aq) and (org) refer to the aqueous and organic phases, respectively. The suggested mechanism of TPC-BCP ion-pair complex formation is presented in Scheme 2.
The stability of the ion-pair complexes was evaluated. The formation of the ion-pairs were rapid and the yellow color extracts were stable 24 h for drug-dye without any change in color intensity and the maximum absorbance at room temperature.
DISCUSSION
Method validation
Linearity At described experimental conditions for TPC determination, standard calibration curves for TPC with BCP and MO calibrations were constructed by plotting absorbance vs. concentration. The statistical parameters were given in the regression equation calculated from the calibration graphs. The proposed methods were validated as per the ICH guidelines. [23−25] The linearity of calibration graphs was proved by the high values of the correlation coefficient (r) and the small values of the y-intercepts of the regression equations. The apparent molar absorptivities (ε) was calculated and found to be 1.641 × 10 4 and 1.072 × 10 4 l mol −1 Cm −1 for BCP and MO ion-pair complexes, respectively, indicating high sensitivity of BCP than MO reagent. Relative standard deviation of response factors for each proposed spectrophotometric method were also calculated and recorded in Table 1 .
Sensitivity
The detection limit (LOD) for the proposed methods was calculated using the following equation: [26] LOD = 3s/k, where s is the standard deviation of replicate determination values under the same conditions as for the sample analysis in the absence of the analyte, and k is the sensitivity, namely the slope of the calibration graph. In accordance with the formula, the detection limits were found to be 0.091 and 0.237 µg ml −1 for BCP and MO methods, respectively.
The limits of quantization, LOQ, is defined as [26] 
LOQ = 10 s/k.
According to this equation, the limit of quantization was found to be 0.303 and 0.791 µg ml −1 for BCP and MO methods, respectively.
Accuracy and precision
Percentage relative standard deviation (RSD%) as precision and percentage relative error (Er%) as accuracy of the suggested method were calculated. Precision was carried out by six determinations at four different concentrations in these spectrophotometric methods. The percentage relative error calculated using the following equation:
The interday and intraday precision and accuracy results are shown in Table 2 . These results of accuracy and precision show that the proposed methods have good repeatability and reproducibility.
Effects of interference
To assess the usefulness of the method, the effect of diluents, excipients and additives which often accompany TPC in its dosage forms (lactose, dextrose, ethanol, starch, propylene glycol, hydroxypropyl methyl cellulose, cellulose) was studied. The results indicated that there is no interference from the degradation, indicating a high selectivity for determining the studied TPC in its dosage forms (eye drops).
Analysis of pharmaceutical preparations
The suggested methods were applied successfully to the determination of TPC in commercial eye drops. Six replicate determinations were made. Table 3 shows that satisfactory recovery data were obtained and the assay results were in a good agreement with the label claims.
Moreover, to check the validity of the proposed methods, dosage forms were tested for possible interference with standard addition method. There was no significant difference between slopes of calibration curves and standard addition methods at two methods. Therefore it is concluded that the excipients in dosage forms of TPC were not found any interference in the analysis of TPC. At 95% confidence level the calculated F-value did not exceed the theoretical F-value indicating no significant difference between the two proposed methods and the offical method (non aqueous titration method described in BP) [12] [ Table 4 ].
CONCLUSION
Spectrophotometric analysis is of major interest in analytical pharmacy since it offers distinct possibility in the assay of a particular component in dosage formulations. In the present study, the maximum color development of TPC with BCP or MO ion-pair complex was instantaneous. No heating or standing was needed. These methods do not involve procedural steps, do not take more operator time and expertise such as HPLC and other methods. In terms of simplicity, rapidity, sensitivity, expense, and free from interference by common additives and excipients, the methods could be considered superior in comparison with the previously reported methods, especially with those based on chromatography or other reported spectrophotometric methods. The reagents utilized in the proposed methods are cheaper, readily available and the procedures do not involve any critical reaction conditions or tedious sample preparation. The method is unaffected by slight variations in experimental conditions such as time, reagent concentration or temperature. The proposed methods gave results with good accuracy to permit determination of low concentrations. The wide applicability of the described procedure for routine quality control is well established by the assay of TPC in pure form, as well as in tablets dosage forms. 
